BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 17304037)

  • 1. The metabolic syndrome in polycystic ovary syndrome.
    Essah PA; Wickham EP; Nestler JE
    Clin Obstet Gynecol; 2007 Mar; 50(1):205-25. PubMed ID: 17304037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A; Amato MC; Giordano C
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico.
    Rabelo Acevedo M; Vick MR
    P R Health Sci J; 2005 Sep; 24(3):203-6. PubMed ID: 16329683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome in polycystic ovary syndrome.
    Carmina E
    Minerva Ginecol; 2006 Apr; 58(2):109-14. PubMed ID: 16582867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician.
    Lorenz LB; Wild RA
    Clin Obstet Gynecol; 2007 Mar; 50(1):226-43. PubMed ID: 17304038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovary syndrome and the metabolic syndrome.
    Weerakiet S
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
    Tomlinson J; Millward A; Stenhouse E; Pinkney J
    Diabet Med; 2010 May; 27(5):498-515. PubMed ID: 20536945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome in the adolescent.
    Pfeifer SM; Kives S
    Obstet Gynecol Clin North Am; 2009 Mar; 36(1):129-52. PubMed ID: 19344852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lifestyle modification in the management of polycystic ovary syndrome.
    Hoeger KM
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):293-310. PubMed ID: 16772159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
    Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
    Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
    Sharma ST; Nestler JE
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic syndrome in young Korean women with polycystic ovary syndrome.
    Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S243-6. PubMed ID: 17610984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New adolescent polycystic ovary syndrome perspectives.
    Alemzadeh R; Kansra AR
    Minerva Pediatr; 2011 Feb; 63(1):35-47. PubMed ID: 21311428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment.
    Tan S; Hahn S; Janssen OE
    Panminerva Med; 2005 Dec; 47(4):211-7. PubMed ID: 16489320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome and the postmenopausal woman.
    Ireland K; Child T
    J Br Menopause Soc; 2006 Dec; 12(4):143-8. PubMed ID: 17178014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.